Recent articles

Type 1 diabetes (T1D) occurs when the body’s immune system attacks the insulin-producing beta cells in the pancreas. But this doesn’t happen overnight—instead, it’s a gradual process of beta cell loss over time. As the immune system attacks and destroys more beta cells, insulin production decreases, leading to abnormal blood-sugar levels. Eventually, enough beta cells are […]

Autoimmune diseases occur when a person’s immune system wrongly attacks the body’s healthy cells, tissues, and organs. This response can result in a range of conditions, depending on which parts of the body are affected. Autoimmune diseases are often called “invisible” because their symptoms are not always evident to the people around you. As a […]

Learn the basics about autoimmune disease, including prevalence in the U.S., possible causes, and why they are often called "invisible."

Nearly 3 years after Breakthrough T1D joined forces with Civica, a non-profit pharmaceutical company, its first insulin is now available for purchase at pharmacies across the country. Check out our story from October that highlights the years of partnership between Civica and Breakthrough T1D that made today a reality. We worked with our partners at […]

What’s happening? Continuous ketone monitoring (CKM) is on its way. A new paper in The Lancet Diabetes & Endocrinology, titled “International expert recommendations on the application and utility of continuous ketone monitoring for people with diabetes,” was published by Breakthrough T1D and expert collaborators, spearheaded by our Chief Medical Officer, International, Thomas Danne, M.D., Ph.D. […]

How quickly a year goes by—and a lot has happened for type 1 diabetes (T1D) in 2025! In these last few weeks leading up to the new year, Breakthrough T1D would like to take a moment to reflect on how far we’ve come in the past 365 days. Read on for the greatest T1D accomplishments […]

Press releases

Read the latest press releases and statements from Breakthrough T1D.

Get the Latest T1D Updates

Sign up for our monthly mission progress newsletter, The Pipeline, to stay up to date on everything you need to know about T1D, from research to advocacy, to clinical care - and everything in between.

  • This field is for validation purposes and should be left unchanged.